{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/allergic-rhinitis/","result":{"data":{"firstChapter":{"id":"5fa28a05-233b-5de6-aee8-ea0327f3c7d6","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 05c91551-7a71-46b8-9b2c-bb2415d35311 --><h1>Allergic rhinitis: Summary</h1><!-- end field 05c91551-7a71-46b8-9b2c-bb2415d35311 -->","htmlStringContent":"<!-- begin item 891fafb1-8f5b-46a3-bf40-7f0ac298a0aa --><!-- begin field cc09bd9a-189c-4e31-bd8d-9eb990a1a71d --><ul><li>Allergic rhinitis is an IgE-mediated inflammatory disorder of the nose which occurs when the nasal mucosa becomes exposed and sensitized to allergens, to produce typical symptoms of sneezing, nasal itching, discharge (rhinorrhoea), and congestion.</li><li>Allergic rhinitis may be classified according to:<ul><li>Seasonal — symptoms occur at the same time each year. If caused by grass and tree pollen allergens, it is also known as 'hay fever'.</li><li>Perennial — symptoms occur throughout the year, typically due to allergens from house dust mites and animal dander.</li><li>Intermittent — symptoms occur for less than four days a week, <em>or</em> less than four consecutive weeks.</li><li>Persistent — symptoms occur for more than four days a week <em>and</em> for more than four consecutive weeks.</li><li>Occupational — symptoms due to exposure to allergens in the work environment, for example, flour allergy in a baker.</li></ul></li><li>Allergic rhinitis is common and its prevalence is increasing in the UK.</li><li>Complications include impaired school and work performance, disturbed sleep, reduced concentration; possible development of asthma, sinusitis, and nasal polyps.</li><li>A diagnosis of allergic rhinitis should be suspected if there are typical clinical features:<ul><li>Classic symptoms which occur following exposure to a known causative allergen.</li><li>Possible associated allergic conjunctivitis, asthma, or eczema.</li></ul></li><li>Assessment of a person with suspected allergic rhinitis should include:<ul><li>The type, frequency, persistence, and location of symptoms.</li><li>The severity and impact of symptoms.</li><li>Housing conditions, pets, and occupation.</li><li>Any drugs that may cause or aggravate symptoms.</li><li>Any family history of atopy.</li><li>Examination for signs and underlying causes of rhinitis, and/or associated conditions.</li></ul></li><li>Initial management of allergic rhinitis should include advice on:<ul><li>Sources of information and support.</li><li>Possible use of nasal irrigation with saline.</li><li>Allergen avoidance techniques if there is a specific identified causative allergen.</li><li>The use of an as-needed intranasal antihistamine or non-sedating oral antihistamine, or an intranasal chromone, for mild-to-moderate intermittent, or mild persistent symptoms.</li><li>The use of a regular intranasal corticosteroid during periods of allergen exposure for moderate-to-severe persistent symptoms, or if initial drug treatment is ineffective.</li><li>Arranging review after 2–4 weeks if symptoms persist, as management may need to be stepped up.</li></ul></li><li>Management of refractory allergic rhinitis should include offering:<ul><li>Possible add-on treatments, such as an intranasal decongestant, intranasal anticholinergic, combination intranasal antihistamine and corticosteroid, or leukotriene receptor antagonist, depending on the nature of symptoms, the person's age, and personal preferences.</li><li>A short course of oral corticosteroid for severe, uncontrolled symptoms that are significantly affecting quality of life.</li></ul></li><li>Referral to an allergy or ear, nose, and throat (ENT) specialist should be arranged if:<ul><li>There are red flag features suggesting an alternative or serious diagnosis.</li><li>There are persistent symptoms despite optimal management in primary care.</li><li>Allergen avoidance techniques such as house dust mite or animal dander avoidance are being considered, as allergy testing may be needed.</li><li>The diagnosis is uncertain, as allergy testing may be needed.</li></ul></li></ul><!-- end field cc09bd9a-189c-4e31-bd8d-9eb990a1a71d --><!-- end item 891fafb1-8f5b-46a3-bf40-7f0ac298a0aa -->","topic":{"id":"e84371ef-9d30-56df-8358-1520fb2c324f","topicId":"0473d89c-2999-40d1-911f-d265b4bd3942","topicName":"Allergic rhinitis","slug":"allergic-rhinitis","aliases":[],"chapters":[{"id":"5fa28a05-233b-5de6-aee8-ea0327f3c7d6","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"ea1f0c07-a5f8-599b-9b96-71ef8590b2a6","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"99b142c6-9593-51c7-9c86-7c8a537a3b8c","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"67cd9666-b198-574f-9fbf-cd740a7d8c3e","slug":"changes","fullItemName":"Changes"},{"id":"7d544db5-f3b7-5709-a2ae-076455d76d20","slug":"update","fullItemName":"Update"}]},{"id":"392391e3-b09a-5cab-ae2a-040eb039abd9","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"292568d8-a1f5-5b8f-a13d-f3c014fa8e95","slug":"goals","fullItemName":"Goals"},{"id":"2f7129b7-e08b-5e5f-997c-4b661ce0a778","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8062582a-18e3-58d5-a8cb-f9689e259444","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1e562233-ae40-5755-abc7-71551f4cea02","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ccab909c-169d-52aa-ac0a-9d425f89a99c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"37d61d5d-e2f1-58ef-9c6a-27c4011784f3","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"84432cb8-00ce-599e-9e05-3493755dacd6","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"f59296af-8e0a-509d-b8f3-692efd2bdb92","slug":"definition","fullItemName":"Definition"},{"id":"37020833-afb2-529a-975a-1f1a7a5db2ef","slug":"causes","fullItemName":"Causes"},{"id":"962f75f0-d73d-5c7c-aaf4-d08fc672e6be","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ab993d04-4c7b-59cd-9e56-2e0ef7fdc9db","slug":"complications","fullItemName":"Complications"},{"id":"68b348fd-2864-5da4-8687-6d8c25004f1b","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"80c9e7d3-3315-55b9-98fb-2261b95a1b5c","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"3cc3ef09-2238-5504-8781-48914ad6a4c9","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"5a3f0e38-3f88-5049-beaa-f4cb26499dc6","slug":"assessment","fullItemName":"Assessment"},{"id":"5bd413c7-0398-5b71-acad-a5699c7c703b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"9b8b1dfa-dfda-5292-a329-64d2c435a006","slug":"management","fullItemName":"Management","subChapters":[{"id":"a132cc60-bb1b-5679-8eda-db080a1e772a","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"760f3c4d-0984-5865-acbe-65d470f66518","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"a47a2aa5-0821-5bf5-987b-2397ac2c982f","slug":"intranasal-antihistamines","fullItemName":"Intranasal antihistamines"},{"id":"449809a3-a714-573e-a21f-8e4295eb984e","slug":"oral-antihistamines","fullItemName":"Oral antihistamines"},{"id":"5507fb81-aa18-5a21-b619-8db3c3c78e80","slug":"intranasal-cromones","fullItemName":"Intranasal cromones"},{"id":"5102b868-dccf-58c1-b6c7-3a59a24c6602","slug":"intranasal-decongestants","fullItemName":"Intranasal decongestants"},{"id":"623ba003-b473-5be2-bc25-e438f1500f7c","slug":"intranasal-anticholinergics","fullItemName":"Intranasal anticholinergics"},{"id":"c871daa0-d649-59f1-b13c-79ab64e7083e","slug":"oral-leukotriene-receptor-antagonists","fullItemName":"Oral leukotriene receptor antagonists"}]},{"id":"f3877d58-da5a-5655-8752-49e87f3a410b","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"87371e7f-8741-54ef-9af6-339f8f0b9285","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"318f5be9-46cf-5fb9-b28c-7ebb4a901904","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"49c3da95-9d4f-5a93-a7ca-e71965fcb981","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"33a2085c-95d6-5004-8f1f-50a08684c638","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"4b1a0d4a-fd5e-5b81-9293-5b2f004871cb","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"735b627c-7d7e-58b8-8196-b4972220342b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"92889a85-b6e7-58f3-9f09-eae6ca76386c","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"e84371ef-9d30-56df-8358-1520fb2c324f","topicId":"0473d89c-2999-40d1-911f-d265b4bd3942","topicName":"Allergic rhinitis","slug":"allergic-rhinitis","aliases":[],"topicSummary":"Allergic rhinitis is an inflammatory disorder of the nose which occurs when the membranes lining the nose become sensitized to allergens.","lastRevised":"Last revised in September 2018","nextPlannedReviewBy":"2023-09-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2023-08","nextPlannedReviewByDisplay":"August 2023","specialities":[{"id":"861c4fe3-02c7-51e0-8f03-a114c375ba4d","name":"Allergies","slug":"allergies"},{"id":"bb606678-e2cc-550b-bd11-bd7b8e7d05e1","name":"Ear, nose and throat","slug":"ear-nose-throat"},{"id":"164e61aa-02a9-5edf-9943-5d891add3a7f","name":"Respiratory","slug":"respiratory"}],"chapters":[{"id":"5fa28a05-233b-5de6-aee8-ea0327f3c7d6","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"ea1f0c07-a5f8-599b-9b96-71ef8590b2a6","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"99b142c6-9593-51c7-9c86-7c8a537a3b8c","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"67cd9666-b198-574f-9fbf-cd740a7d8c3e","slug":"changes","fullItemName":"Changes"},{"id":"7d544db5-f3b7-5709-a2ae-076455d76d20","slug":"update","fullItemName":"Update"}]},{"id":"392391e3-b09a-5cab-ae2a-040eb039abd9","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"292568d8-a1f5-5b8f-a13d-f3c014fa8e95","slug":"goals","fullItemName":"Goals"},{"id":"2f7129b7-e08b-5e5f-997c-4b661ce0a778","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8062582a-18e3-58d5-a8cb-f9689e259444","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1e562233-ae40-5755-abc7-71551f4cea02","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ccab909c-169d-52aa-ac0a-9d425f89a99c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"37d61d5d-e2f1-58ef-9c6a-27c4011784f3","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"84432cb8-00ce-599e-9e05-3493755dacd6","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"f59296af-8e0a-509d-b8f3-692efd2bdb92","slug":"definition","fullItemName":"Definition"},{"id":"37020833-afb2-529a-975a-1f1a7a5db2ef","slug":"causes","fullItemName":"Causes"},{"id":"962f75f0-d73d-5c7c-aaf4-d08fc672e6be","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ab993d04-4c7b-59cd-9e56-2e0ef7fdc9db","slug":"complications","fullItemName":"Complications"},{"id":"68b348fd-2864-5da4-8687-6d8c25004f1b","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"80c9e7d3-3315-55b9-98fb-2261b95a1b5c","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"3cc3ef09-2238-5504-8781-48914ad6a4c9","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"5a3f0e38-3f88-5049-beaa-f4cb26499dc6","slug":"assessment","fullItemName":"Assessment"},{"id":"5bd413c7-0398-5b71-acad-a5699c7c703b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"9b8b1dfa-dfda-5292-a329-64d2c435a006","slug":"management","fullItemName":"Management","subChapters":[{"id":"a132cc60-bb1b-5679-8eda-db080a1e772a","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"760f3c4d-0984-5865-acbe-65d470f66518","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"a47a2aa5-0821-5bf5-987b-2397ac2c982f","slug":"intranasal-antihistamines","fullItemName":"Intranasal antihistamines"},{"id":"449809a3-a714-573e-a21f-8e4295eb984e","slug":"oral-antihistamines","fullItemName":"Oral antihistamines"},{"id":"5507fb81-aa18-5a21-b619-8db3c3c78e80","slug":"intranasal-cromones","fullItemName":"Intranasal cromones"},{"id":"5102b868-dccf-58c1-b6c7-3a59a24c6602","slug":"intranasal-decongestants","fullItemName":"Intranasal decongestants"},{"id":"623ba003-b473-5be2-bc25-e438f1500f7c","slug":"intranasal-anticholinergics","fullItemName":"Intranasal anticholinergics"},{"id":"c871daa0-d649-59f1-b13c-79ab64e7083e","slug":"oral-leukotriene-receptor-antagonists","fullItemName":"Oral leukotriene receptor antagonists"}]},{"id":"f3877d58-da5a-5655-8752-49e87f3a410b","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"87371e7f-8741-54ef-9af6-339f8f0b9285","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"318f5be9-46cf-5fb9-b28c-7ebb4a901904","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"49c3da95-9d4f-5a93-a7ca-e71965fcb981","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"33a2085c-95d6-5004-8f1f-50a08684c638","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"4b1a0d4a-fd5e-5b81-9293-5b2f004871cb","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"735b627c-7d7e-58b8-8196-b4972220342b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"92889a85-b6e7-58f3-9f09-eae6ca76386c","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"e84371ef-9d30-56df-8358-1520fb2c324f"}},"staticQueryHashes":["3666801979"]}